The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas

The prognostic role of TGF-β signaling pathway in breast cancer patients

(2012) E. M. de Kruijf et al.   ANNALS OF ONCOLOGY

Thrombospondin-1 (TSP-1) Analogs ABT-510 and ABT-898 Inhibit Prolactinoma Growth and Recover Active Pituitary Transforming Growth Factor-β1 (TGF-β1)

(2012) M. Victoria Recouvreux et al.   ENDOCRINOLOGY

TGFβ signalling in context

(2012) Joan Massagué   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer

(2012) Yijun Wu et al.   PLoS One

Active and Total Transforming Growth Factor-β1 Are Differentially Regulated by Dopamine and Estradiol in the Pituitary

(2011) M. Victoria Recouvreux et al.   ENDOCRINOLOGY

In Nonfunctional Pituitary Adenomas, Estrogen Receptors and Slug Contribute to Development of Invasiveness

(2011) Wei Zhou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pathogenesis of pituitary tumors

(2011) Shlomo Melmed   Nature Reviews Endocrinology

Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas

(2010) Mahlon D. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

Smad7 induces hepatic metastasis in colorectal cancer

(2008) S K Halder et al.   BRITISH JOURNAL OF CANCER

TGFβ in Cancer

(2008) Joan Massagué   CELL

Medical therapy for clinically non-functioning pituitary adenomas

(2008) A. Colao et al.   ENDOCRINE-RELATED CANCER

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols

Management of aggressive pituitary adenomas: current treatment strategies

(2008) Michael Buchfelder   Pituitary